La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Relationship between arterial blood pressure disturbances and alpha adrenoceptor density

Identifieur interne : 001676 ( PascalFrancis/Curation ); précédent : 001675; suivant : 001677

Relationship between arterial blood pressure disturbances and alpha adrenoceptor density

Auteurs : M. Galinier [France] ; J. M. Senard [France] ; P. Valet [France] ; J. P. Doazan [France] ; G. Durrieu [France] ; M. A. Tran [France] ; J. L. Monstastruc [France] ; J. P. Bounhoure

Source :

RBID : Pascal:94-0460899

Descripteurs français

English descriptors

pA  
A01 01  1    @0 1064-1963
A03   1    @0 Clin. exp. hypertens. : (1993)
A05       @2 16
A06       @2 3
A08 01  1  ENG  @1 Relationship between arterial blood pressure disturbances and alpha adrenoceptor density
A11 01  1    @1 GALINIER (M.)
A11 02  1    @1 SENARD (J. M.)
A11 03  1    @1 VALET (P.)
A11 04  1    @1 DOAZAN (J. P.)
A11 05  1    @1 DURRIEU (G.)
A11 06  1    @1 TRAN (M. A.)
A11 07  1    @1 MONSTASTRUC (J. L.)
A11 08  1    @1 BOUNHOURE (J. P.)
A14 01      @1 Rangueil hosp., dep. cardiology @2 31054 Toulouse @3 FRA @Z 1 aut. @Z 2 aut. @Z 4 aut. @Z 7 aut.
A14 02      @1 INSERM, U 317 dep. pharmacology @2 Toulouse @3 FRA @Z 2 aut. @Z 3 aut. @Z 5 aut. @Z 6 aut. @Z 7 aut.
A20       @1 373-389
A21       @1 1994
A23 01      @0 ENG
A43 01      @1 INIST @2 18049 A @5 354000046141460080
A44       @0 0000
A45       @0 22 ref.
A47 01  1    @0 94-0460899
A60       @1 P
A61       @0 A
A64 01  1    @0 Clinical and experimental hypertension : (1993)
A66 01      @0 USA
C02 01  X    @0 002B12B05B
C03 01  X  FRE  @0 Hypertension artérielle @2 NM @2 L1 @5 01
C03 01  X  ENG  @0 Hypertension @2 NM @2 L1 @5 01
C03 01  X  SPA  @0 Hipertensión arterial @2 NM @2 L1 @5 01
C03 02  X  FRE  @0 Essentiel @2 L1 @5 02
C03 02  X  ENG  @0 Essential @2 L1 @5 02
C03 02  X  SPA  @0 Esencial @2 L1 @5 02
C03 03  X  FRE  @0 Homme @5 03
C03 03  X  ENG  @0 Human @5 03
C03 03  X  SPA  @0 Hombre @5 03
C03 04  X  FRE  @0 Corrélation @5 04
C03 04  X  ENG  @0 Correlation @5 04
C03 04  X  SPA  @0 Correlación @5 04
C03 05  X  FRE  @0 Pression artérielle @5 05
C03 05  X  ENG  @0 Arterial pressure @5 05
C03 05  X  SPA  @0 Presión arterial @5 05
C03 06  X  FRE  @0 Densité @5 06
C03 06  X  ENG  @0 Density @5 06
C03 06  X  SPA  @0 Densidad @5 06
C03 07  X  FRE  @0 Récepteur α2-adrénergique @5 07
C03 07  X  ENG  @0 α2-Adrenergic receptor @5 07 @6 «α2-»Adrenergic receptor
C03 07  X  SPA  @0 Receptor α2-adrenérgico @5 07
C03 08  X  FRE  @0 Thrombocyte @5 08
C03 08  X  ENG  @0 Platelet @5 08
C03 08  X  SPA  @0 Trombocito @5 08
C03 09  X  FRE  @0 Etude comparative @5 09
C03 09  X  ENG  @0 Comparative study @5 09
C03 09  X  GER  @0 Vergleich @5 09
C03 09  X  SPA  @0 Estudio comparativo @5 09
C03 10  X  FRE  @0 Parkinson maladie @2 NM @5 10
C03 10  X  ENG  @0 Parkinson disease @2 NM @5 10
C03 10  X  SPA  @0 Parkinson enfermedad @2 NM @5 10
C07 01  X  FRE  @0 Appareil circulatoire pathologie @5 37
C07 01  X  ENG  @0 Cardiovascular disease @5 37
C07 01  X  SPA  @0 Aparato circulatorio patología @5 37
C07 02  X  FRE  @0 Système nerveux pathologie @5 61
C07 02  X  ENG  @0 Nervous system diseases @5 61
C07 02  X  SPA  @0 Sistema nervioso patología @5 61
C07 03  X  FRE  @0 Système nerveux central pathologie @5 62
C07 03  X  ENG  @0 Central nervous system disease @5 62
C07 03  X  SPA  @0 Sistema nervosio central patología @5 62
C07 04  X  FRE  @0 Encéphale pathologie @5 63
C07 04  X  ENG  @0 Cerebral disorder @5 63
C07 04  X  SPA  @0 Encéfalo patología @5 63
C07 05  X  FRE  @0 Extrapyramidal syndrome @5 64
C07 05  X  ENG  @0 Extrapyramidal syndrome @5 64
C07 05  X  SPA  @0 Extrapiramidal síndrome @5 64
C07 06  X  FRE  @0 Maladie dégénérative @5 65
C07 06  X  ENG  @0 Degenerative disease @5 65
C07 06  X  SPA  @0 Enfermedad degenerativa @5 65
N21       @1 208

Links toward previous steps (curation, corpus...)


Links to Exploration step

Pascal:94-0460899

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Relationship between arterial blood pressure disturbances and alpha adrenoceptor density</title>
<author>
<name sortKey="Galinier, M" sort="Galinier, M" uniqKey="Galinier M" first="M." last="Galinier">M. Galinier</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Rangueil hosp., dep. cardiology</s1>
<s2>31054 Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Senard, J M" sort="Senard, J M" uniqKey="Senard J" first="J. M." last="Senard">J. M. Senard</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Rangueil hosp., dep. cardiology</s1>
<s2>31054 Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>INSERM, U 317 dep. pharmacology</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Valet, P" sort="Valet, P" uniqKey="Valet P" first="P." last="Valet">P. Valet</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>INSERM, U 317 dep. pharmacology</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Doazan, J P" sort="Doazan, J P" uniqKey="Doazan J" first="J. P." last="Doazan">J. P. Doazan</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Rangueil hosp., dep. cardiology</s1>
<s2>31054 Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Durrieu, G" sort="Durrieu, G" uniqKey="Durrieu G" first="G." last="Durrieu">G. Durrieu</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>INSERM, U 317 dep. pharmacology</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Tran, M A" sort="Tran, M A" uniqKey="Tran M" first="M. A." last="Tran">M. A. Tran</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>INSERM, U 317 dep. pharmacology</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Monstastruc, J L" sort="Monstastruc, J L" uniqKey="Monstastruc J" first="J. L." last="Monstastruc">J. L. Monstastruc</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Rangueil hosp., dep. cardiology</s1>
<s2>31054 Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>INSERM, U 317 dep. pharmacology</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Bounhoure, J P" sort="Bounhoure, J P" uniqKey="Bounhoure J" first="J. P." last="Bounhoure">J. P. Bounhoure</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">94-0460899</idno>
<date when="1994">1994</date>
<idno type="stanalyst">PASCAL 94-0460899 INIST</idno>
<idno type="RBID">Pascal:94-0460899</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001976</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001676</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Relationship between arterial blood pressure disturbances and alpha adrenoceptor density</title>
<author>
<name sortKey="Galinier, M" sort="Galinier, M" uniqKey="Galinier M" first="M." last="Galinier">M. Galinier</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Rangueil hosp., dep. cardiology</s1>
<s2>31054 Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Senard, J M" sort="Senard, J M" uniqKey="Senard J" first="J. M." last="Senard">J. M. Senard</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Rangueil hosp., dep. cardiology</s1>
<s2>31054 Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>INSERM, U 317 dep. pharmacology</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Valet, P" sort="Valet, P" uniqKey="Valet P" first="P." last="Valet">P. Valet</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>INSERM, U 317 dep. pharmacology</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Doazan, J P" sort="Doazan, J P" uniqKey="Doazan J" first="J. P." last="Doazan">J. P. Doazan</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Rangueil hosp., dep. cardiology</s1>
<s2>31054 Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Durrieu, G" sort="Durrieu, G" uniqKey="Durrieu G" first="G." last="Durrieu">G. Durrieu</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>INSERM, U 317 dep. pharmacology</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Tran, M A" sort="Tran, M A" uniqKey="Tran M" first="M. A." last="Tran">M. A. Tran</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>INSERM, U 317 dep. pharmacology</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Monstastruc, J L" sort="Monstastruc, J L" uniqKey="Monstastruc J" first="J. L." last="Monstastruc">J. L. Monstastruc</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Rangueil hosp., dep. cardiology</s1>
<s2>31054 Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>INSERM, U 317 dep. pharmacology</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Bounhoure, J P" sort="Bounhoure, J P" uniqKey="Bounhoure J" first="J. P." last="Bounhoure">J. P. Bounhoure</name>
</author>
</analytic>
<series>
<title level="j" type="main">Clinical and experimental hypertension : (1993)</title>
<title level="j" type="abbreviated">Clin. exp. hypertens. : (1993)</title>
<idno type="ISSN">1064-1963</idno>
<imprint>
<date when="1994">1994</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Clinical and experimental hypertension : (1993)</title>
<title level="j" type="abbreviated">Clin. exp. hypertens. : (1993)</title>
<idno type="ISSN">1064-1963</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Arterial pressure</term>
<term>Comparative study</term>
<term>Correlation</term>
<term>Density</term>
<term>Essential</term>
<term>Human</term>
<term>Hypertension</term>
<term>Parkinson disease</term>
<term>Platelet</term>
<term>α2-Adrenergic receptor</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Hypertension artérielle</term>
<term>Essentiel</term>
<term>Homme</term>
<term>Corrélation</term>
<term>Pression artérielle</term>
<term>Densité</term>
<term>Récepteur α2-adrénergique</term>
<term>Thrombocyte</term>
<term>Etude comparative</term>
<term>Parkinson maladie</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>1064-1963</s0>
</fA01>
<fA03 i2="1">
<s0>Clin. exp. hypertens. : (1993)</s0>
</fA03>
<fA05>
<s2>16</s2>
</fA05>
<fA06>
<s2>3</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Relationship between arterial blood pressure disturbances and alpha adrenoceptor density</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>GALINIER (M.)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>SENARD (J. M.)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>VALET (P.)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>DOAZAN (J. P.)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>DURRIEU (G.)</s1>
</fA11>
<fA11 i1="06" i2="1">
<s1>TRAN (M. A.)</s1>
</fA11>
<fA11 i1="07" i2="1">
<s1>MONSTASTRUC (J. L.)</s1>
</fA11>
<fA11 i1="08" i2="1">
<s1>BOUNHOURE (J. P.)</s1>
</fA11>
<fA14 i1="01">
<s1>Rangueil hosp., dep. cardiology</s1>
<s2>31054 Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>INSERM, U 317 dep. pharmacology</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</fA14>
<fA20>
<s1>373-389</s1>
</fA20>
<fA21>
<s1>1994</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>18049 A</s2>
<s5>354000046141460080</s5>
</fA43>
<fA44>
<s0>0000</s0>
</fA44>
<fA45>
<s0>22 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>94-0460899</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Clinical and experimental hypertension : (1993)</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC02 i1="01" i2="X">
<s0>002B12B05B</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Hypertension artérielle</s0>
<s2>NM</s2>
<s2>L1</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Hypertension</s0>
<s2>NM</s2>
<s2>L1</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Hipertensión arterial</s0>
<s2>NM</s2>
<s2>L1</s2>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Essentiel</s0>
<s2>L1</s2>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Essential</s0>
<s2>L1</s2>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Esencial</s0>
<s2>L1</s2>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Homme</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Human</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Hombre</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Corrélation</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Correlation</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Correlación</s0>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Pression artérielle</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Arterial pressure</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Presión arterial</s0>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Densité</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Density</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Densidad</s0>
<s5>06</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Récepteur α2-adrénergique</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>α2-Adrenergic receptor</s0>
<s5>07</s5>
<s6>«α2-»Adrenergic receptor</s6>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Receptor α2-adrenérgico</s0>
<s5>07</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>Thrombocyte</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>Platelet</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA">
<s0>Trombocito</s0>
<s5>08</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE">
<s0>Etude comparative</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG">
<s0>Comparative study</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="GER">
<s0>Vergleich</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA">
<s0>Estudio comparativo</s0>
<s5>09</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE">
<s0>Parkinson maladie</s0>
<s2>NM</s2>
<s5>10</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG">
<s0>Parkinson disease</s0>
<s2>NM</s2>
<s5>10</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA">
<s0>Parkinson enfermedad</s0>
<s2>NM</s2>
<s5>10</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Appareil circulatoire pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Cardiovascular disease</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Aparato circulatorio patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Système nerveux pathologie</s0>
<s5>61</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Nervous system diseases</s0>
<s5>61</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Sistema nervioso patología</s0>
<s5>61</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Système nerveux central pathologie</s0>
<s5>62</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Central nervous system disease</s0>
<s5>62</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Sistema nervosio central patología</s0>
<s5>62</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Encéphale pathologie</s0>
<s5>63</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Cerebral disorder</s0>
<s5>63</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Encéfalo patología</s0>
<s5>63</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Extrapyramidal syndrome</s0>
<s5>64</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Extrapyramidal syndrome</s0>
<s5>64</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Extrapiramidal síndrome</s0>
<s5>64</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE">
<s0>Maladie dégénérative</s0>
<s5>65</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG">
<s0>Degenerative disease</s0>
<s5>65</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA">
<s0>Enfermedad degenerativa</s0>
<s5>65</s5>
</fC07>
<fN21>
<s1>208</s1>
</fN21>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PascalFrancis/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001676 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 001676 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:94-0460899
   |texte=   Relationship between arterial blood pressure disturbances and alpha adrenoceptor density
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024